124 related articles for article (PubMed ID: 2795090)
1. Treatment of renal cell carcinoma with daily low-dose alpha-interferon.
Marshall ME; Simpson W; Butler K; Fried A; Fer M
J Biol Response Mod; 1989 Oct; 8(5):453-61. PubMed ID: 2795090
[TBL] [Abstract][Full Text] [Related]
2. Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
Tannir NM; Cohen L; Wang X; Thall P; Mathew PF; Jonasch E; Siefker-Radtke A; Pagliaro LC; Ng CS; Logothetis C
Cancer; 2006 Nov; 107(9):2254-61. PubMed ID: 17029276
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
Buzaid AC; Robertone A; Kisala C; Salmon SE
J Clin Oncol; 1987 Jul; 5(7):1083-9. PubMed ID: 3598612
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.
Quesada JR; Swanson DA; Gutterman JU
J Clin Oncol; 1985 Aug; 3(8):1086-92. PubMed ID: 4020410
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial.
Amato RJ; Jac J; Hernandez-McClain J
Anticancer Drugs; 2008 Jun; 19(5):527-33. PubMed ID: 18418219
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.
Figlin RA; deKernion JB; Mukamel E; Palleroni AV; Itri LM; Sarna GP
J Clin Oncol; 1988 Oct; 6(10):1604-10. PubMed ID: 3049952
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie.
Ravaud A; Delva R; Gomez F; Chevreau C; Douillard JY; Peny J; Coudert B; Négrier S;
Cancer; 2002 Dec; 95(11):2324-30. PubMed ID: 12436438
[TBL] [Abstract][Full Text] [Related]
10. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
Fosså SD; Gunderson R; Moe B
Cancer; 1990 Jun; 65(11):2451-4. PubMed ID: 2337859
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Marshall ME; Wolf M; Crawford ED; Thompson IM; Flanigan R; Balcerzak SP; Meyers FJ
Cancer Biother; 1995; 10(3):205-9. PubMed ID: 8547959
[TBL] [Abstract][Full Text] [Related]
13. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission of lung and hepatic metastases from renal cell carcinoma by interferon alpha-2b therapy: a case report].
Okaneya T; Murata Y; Kinebuchi Y
Hinyokika Kiyo; 1999 Sep; 45(9):617-9. PubMed ID: 10540707
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.
Ellerhorst JA; Sella A; Amato RJ; Tu SM; Millikan RE; Finn LD; Banks M; Logothetis CJ
Cancer; 1997 Dec; 80(11):2128-32. PubMed ID: 9392335
[TBL] [Abstract][Full Text] [Related]
16. Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study.
Dutcher JP; Fisher RI; Weiss G; Aronson F; Margolin K; Louie A; Mier J; Caliendo G; Sosman JA; Eckardt JR; Ernest ML; Doroshow J; Atkins M
Cancer J Sci Am; 1997; 3(3):157-62. PubMed ID: 9161781
[TBL] [Abstract][Full Text] [Related]
17. Roferon-A in solid tumor therapy.
Semin Oncol; 1989 Feb; 16(1 Suppl 1):1-50. PubMed ID: 2919287
[No Abstract] [Full Text] [Related]
18. Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis.
Akaza H; Kawai K; Tsukamoto T; Fujioka T; Tomita Y; Kitamura T; Ozono S; Miki T; Naito S; Zembutsu H; Nakamura Y
Jpn J Clin Oncol; 2010 Jul; 40(7):684-9. PubMed ID: 20382632
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of recombinant alpha-2b-interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma.
Wadler S; Einzig AI; Dutcher JP; Ciobanu N; Landau L; Wiernik PH
Am J Clin Oncol; 1988 Feb; 11(1):55-9. PubMed ID: 3277375
[TBL] [Abstract][Full Text] [Related]
20. Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.
Aksoy H; Baltaci S; Türkölmez K; Seçkiner I; Bedük Y
Int Urol Nephrol; 2001; 33(3):457-9. PubMed ID: 12230271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
